High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes

Experimental Neurology

Volumn 153, Issue 1, 1998, Pages 152-155

  Ghebremedhin, Estifanos ^a   Schultz, Christian ^a   Braak, Eva ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Age; Alzheimer's disease; Apolipoprotein E; Neurofibrillary changes; Preclinical phase; Staging; 4 allele

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; DISEASE COURSE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031664361     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6860     Document Type: Article

References (19)

1. Arriagada, P. V., J. H. Growdon, T. Hedley-Whyte, and B. T. Hyman. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639.
2. Bancher, C., K. Jellinger, H. Lassmann, and P. Fischer. 1996. Correlations between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur. Arch. Psychiat. Clin. Neurosci. 246: 137-146.
3. Braak, H., and E. Braak. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82: 239-259.
4. Braak, H., and E. Braak. 1994. Pathology of Alzheimer's disease. In Neurodegenerative Diseases (D. B. Calne, Eds), pp. 585-613. Saunders, Philadelphia.
5. Braak, H., and E. Braak. 1997. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18: 351-357.
6. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261: 921-923.
7. Duyckaerts, C., J.-P. Brion, J.-J. Hauw, and J. Flament-Durand. 1987. Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method. Acta Neuropathol. (Berlin) 73: 167-170.
8. Ghebremedhin, E., H. Braak, E. Braak, and J. Sahm. 1998. Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens. J. Neurosci. Methods 79: 229-231.
9. Nagy, Zs., M. M. Esiri, K. A. Jobst, C. Johnston, S. Litchfield, E. Sim, and A. D. Smith. 1995. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69: 757-761.
10. Ohm, T. G., H. Müller, H. Braak, and J. Bohl. 1995. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64: 209-217.
11. Ohm, T. G., M. Kirca, J. Bohl, H. Scharnagl, W. Groß, and W. März. 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66: 583-587.
12. Poirier, J., J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
13. Poirier, J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17: 525-530.
14. Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. George-Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. Crapper-MacLachlan, M. J. Alberts, C. Hulette, B. Crain, D. Goldgaber, and A. D. Roses. 1993. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
15. Saunders, A. M., C. Hulette, K. A. Welsh-Bohmer, D. E. Schmechel, B. Crain, J. R. Burke, M. J. Alberts, W. J. Strittmatter, J. C. S. Breitner, C. Rosenberg, S. V. Scott, P. C. Gaskell, M. A. Pericak-Vance, and A. D. Roses. 1996. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 348: 90-93.
16. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type ∈4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
17. Strittmatter, W. J., K. H. Weisgraber, M. Goedert, A. M. Saunders, D. Huang, E. H. Corder, L. M. Dong, R. Jakes, M. J. Alberts, J. R. Gilbert, S.-H. Han, C. Hulette, G. Einstein, D. E. Schmechel, M. A. Pericak-Vance, and A. D. Roses. 1994. Hypothesis: Microtuble instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125: 163-171.
18. Utermann, G., A. Steinmetz, and W. Weber. 1982. Genetic control of human Apolipoprotein E polymorphism: Comparison of one- and two-dimentional techniques of isoprotein analysis. Hum. Genet. 60: 344-351.
19. Zubenko, G. S., S. Stiffler, S. Stabler, U. Kopp, H. B. Hughes, B. M. Cohen, and J. Moossy. 1994. Association of apolipoprotein E E4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am. J. Med. Genet. 54: 199-205.